Neurocircuitry Modulation Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۱-۱۵ از ۱۳۰ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Markus Heiligمشاهده پروفایل

استاد

Linköping UniversitySweden

Markus Heilig is a Professor of Psychiatry and Head of the Department of Biomedical and Clinical Sciences (BKV) at Linköping University. He serves as Director of the Center for Social and Affective Neuroscience (CSAN), integrating basic and clinical neuroscience to address addictive and affective disorders. His work bridges neuropharmacology, molecular psychiatry, and clinical trials. Linköping University (Current) Center for Social and Affective Neuroscience (CSAN) (Director) Wallenberg Center for Molecular Medicine (Collaborator) His research focuses on alcohol dependence mechanisms, stress-neurotransmitter interactions (e.g., CRF, substance P, endocannabinoids), and personalized medicine approaches. Using animal models and human neuroimaging (fMRI), his lab explores epigenetic changes in frontal lobe and amygdala neurons that drive compulsive alcohol use. Recent publications highlight his work on endocannabinoid modulation for PTSD treatment, neural correlates of reward choices, and pharmacological interventions targeting GABA and opioid receptors. His studies often combine brain imaging, behavioral analysis, and pharmacology. Scientific awards include the 2019 Wallenberg Clinical Scholar grant and 2017 CAN/Nordic Drugs prizes. Heilig's research is supported by Vetenskapsrådet (SEK 57 million center funding) and international donations like the Andrew J. Bock Memorial Fund.

پروفایل رسمی دانشگاه

Eva Kosekمشاهده پروفایل

استاد

Karolinska InstitutetSweden

Professor Eva Kosek holds dual academic positions as Professor of Clinical Pain Research at Karolinska Institutet (since 2015) and Uppsala University (since 2020). She is affiliated with the Department of Clinical Neuroscience and leads the Mechanisms of Pain and Treatment Research Group . Her roles include senior consultant at Uppsala University Hospital's Pain Center. Education: MD from Uppsala University (1986), PhD from Karolinska Institutet (1996). Specializations: Rehabilitation Medicine (1998), Pain Relief (2001). Academic promotions: Associate Professor at Karolinska (2004), Full Professor (2015). Research Focus: Chronic pain mechanisms, neuroimmune interactions, fibromyalgia, and autoimmune pathways. Key projects include the RAFT trial (Rituximab for fibromyalgia autoantibody therapy) and the BACPAP consortium for low back pain phenotyping. She chairs IASP's Terminology Task Force, introducing the 'nociplastic pain' concept. Key Contributions: Discovered anti-satellite glial cell IgG antibodies in fibromyalgia patients, linked to symptom severity. Pioneered neuroimaging studies on pain modulation circuits. Authored over 300 publications, with recent work on cerebrospinal fluid biomarkers and lipid metabolite profiles. Awards: 2024 Roland Melzack Lecture Award from IASP. Recognized for redefining pain taxonomy and translational research. Grants: Active funding includes Swedish Research Council grants on fibromyalgia autoimmunity, environmental exposures, and neuroinflammation. Total grants exceed SEK 100M over her career. Labs/Teams: Leads a multidisciplinary team at Karolinska's Pain Research Center, collaborating internationally on translational pain studies. Active in biobanking initiatives like the Swedish Chronic Pain Biobank.

پروفایل رسمی دانشگاه

Anna Mathia Klawonnمشاهده پروفایل

دانشیار

Aarhus UniversityDenmark

Anna Mathia Klawonn is an Associate Professor affiliated with three units at Aarhus University: the Danish Research Institute of Translational Neuroscience (DANDRITE), the Department of Biomedicine, and the Department of Molecular Biology and Genetics - Neurobiology. As a group leader at DANDRITE, she explores neural circuits and immune-to-brain signaling mechanisms regulating affective states through transgenic strategies and neurocircuitry techniques. Neuroscience Neuroimmunology Immune-to-Brain Signaling Affective Disorders Her research focuses on understanding how brain circuits and glial cells (microglia and astrocytes) contribute to affective states in both health and disease. Current projects investigate mechanisms in major depressive disorder and Parkinson's disease, emphasizing prostaglandin signaling, nicotinic receptor function, and striatal neuron modulation. Recent publications highlight her work in molecular neuroscience, neuropharmacology, and behavioral neuroscience. Key themes include cholinergic transmission in motivation, neuroimmune interactions in aversion, and reward/aversion circuitry. Her studies employ advanced neurocircuitry methods and transgenic models. In teaching, Klawonn is course responsible for the 3rd-semester Neuroscience course (10 ECTS) in the medical bachelor program. She actively engages in didactic development, frequently speaking about student motivation, flipped learning, and challenge-based learning. Klawonn leads the Klawonn Group at DANDRITE, with lab and office spaces in the Skou Building (Høegh-Guldbergs Gade 10, Aarhus C). Her work involves collaborations across neuroscience, neuroimmunology, and affective disease research.

پروفایل رسمی دانشگاه

Kristen Pleilمشاهده پروفایل

دانشیار

Cornell UniversityUnited States

Kristen Pleil is an Associate Professor at Weill Cornell Medicine in the Graduate School of Medical Sciences, affiliated with the Department of Pharmacology and Neuroscience. She serves as Co-director of the NIGMS-sponsored Training in Pharmacological Sciences (TIPS) predoctoral T32 program. Academic Appointments: Assistant Professor (2016), Associate Professor (2021) Education: BA in Psychology (Emory University, 2005), PhD in Neuroscience (Duke University, 2010), Postdoc at University of North Carolina School of Medicine Research Focus: The Pleil lab investigates how sex and stress hormones regulate alcohol/substance use, stress responsivity, and affective behavior through neuropeptidergic brain circuits and hormone-neuropeptide signaling. Key projects include estrogen's role in alcohol drinking and anxiety, opioid receptor signaling in reward/aversion learning, and sex-dependent thalamic control of stress responses. The lab uses in vivo and ex vivo mouse models to study synaptic/epigenetic plasticity across developmental stages. Publications Trends: Her work spans molecular pharmacology, neurophysiology, and addiction research with a focus on sex differences in neuropsychiatric diseases. Articles cover topics like estrogen signaling in binge drinking, opioid-context memory, thalamic circuits in stress response, and optogenetic tools for receptor imaging. Scientific Awards: President’s Young Investigator Award, ISBRA (2013) Elizabeth Young New Investigator Award, OSSD (2015) K99/R00 Pathway to Independence Award, NIAAA (2015) Kellen Foundation Junior Faculty Fellowship (2016) NARSAD Young Investigator Award (2017) Early Career Investigator Award, NIDA-NIAAA (2017) Training and Collaborations: As Co-director of the TIPS T32 program, she mentors graduate students in pharmacological sciences. Her collaborations include researchers at UNC, Duke, and Weill Cornell, with grants from NIAAA, NIMH, and NIGMS.

پروفایل رسمی دانشگاه

Barbara L. Hempsteadمشاهده پروفایل

استاد

Cornell UniversityUnited States

Dr. Barbara L. Hempstead is a Professor of Neuroscience and Medicine at Weill Cornell Medical College, where she has held positions since 2001 and 2002 respectively. Her research focuses on neurotrophin signaling mechanisms, particularly the roles of BDNF and its receptors in neuroinflammation, synaptic plasticity, and neurodegenerative diseases. She has made significant contributions to understanding proBDNF/proNGF signaling pathways in neuronal apoptosis and vascular biology. Education: M.D., Ph.D., Washington University School of Medicine (1982) B.A., Tufts University (1976) Dr. Hempstead's work bridges molecular neuroscience and cardiovascular biology, with a particular interest in receptor stoichiometry (p75NTR, TrkB), neurotrophin-induced synaptic remodeling, and therapeutic applications of neurotrophin modulators in Huntington's disease and post-seizure neuronal injury. Her lab investigates how genetic variants like BDNF Val66Met influence anxiety-related behaviors, social memory, and neurodegenerative disease progression through altered neurotrophin trafficking and signaling. Her recent publications highlight neuroinflammatory mechanisms (2023), immune-neurotrophin interactions (2022), and molecular pathways involving BDNF prodomain structure (2020) and SorCS2-mediated receptor trafficking (2017-2020). While no scientific awards are explicitly mentioned in the scraped text, her funded research (National Institute on Aging, NIMH) demonstrates sustained recognition of her work in neurotrophin biology. Dr. Hempstead's lab develops in vitro and in vivo models to study neurotrophin-receptor dynamics, including 3D culture systems for angiogenesis research and transgenic mouse models for Huntington's disease. Her interdisciplinary approach combines molecular neurobiology with vascular physiology to uncover novel therapeutic targets for neurological and cardiovascular conditions.

پروفایل رسمی دانشگاه

Marvin Diazمشاهده پروفایل

دانشیار

Binghamton University SUNYUnited States

Marvin Diaz is an Associate Professor and Behavioral Neuroscience Area Head at the Department of Psychology, Binghamton University. His research focuses on understanding neurobiological and behavioral alterations caused by early developmental insults such as prenatal drug exposure, with emphasis on sex differences. He employs advanced techniques including electrophysiology, optogenetics, and molecular biology. His work addresses mechanisms underlying anxiety disorders, substance misuse, and neurodevelopmental trajectories. Education: PhD and MA from Wake Forest University School of Medicine, BS from University of NC at Wilmington. Research Interests: Neurodevelopment, prenatal drug exposure, substance use disorder, neural circuits, and the role of sex as a biological variable. Key Findings: Demonstrated that prenatal methadone/alcohol exposure alters amygdala function, GABAergic transmission, and ethanol intake behavior in sex-dependent ways. Highlighted cytokine modulation of adolescent neurophysiology and stress-related behaviors. Awards: SUNY Faculty Diversity Award (202?), Gordon Conference Minority Fellowship (202?), Dean’s Research Semester Award (202?). Labs: Director of the Alcohol Development Lab. Active in studying developmental neurotoxicology and stress-anxiety interactions.

پروفایل رسمی دانشگاه

Sharmili Edwin Thanarajahمشاهده پروفایل

پژوهشگر

Max Planck Institute for Empirical AestheticsGermany

Sharmili Edwin Thanarajah is a researcher at the Goethe University Frankfurt , affiliated with the Faculty of Medicine and the Department of Psychiatry, Psychosomatics and Psychotherapy . Her work focuses on the intersection of peripheral metabolism, brain signaling, and mental health, utilizing advanced neuroimaging and intervention studies. Research Interests Impact of dietary factors on brain function Metabolism-neurocircuitry interactions Neuromodulation via vagus nerve stimulation Intranasal insulin's effects on cognition Translational psychiatry Key Publications Her research spans multidisciplinary areas including: Modulating midbrain activity through metabolic interventions Anti-inflammatory effects of vagus nerve stimulation Linking reward processing to habitual dietary patterns Neuroimaging-based studies of eating behavior Clinical applications of neuromodulation techniques Methods & Expertise She employs functional MRI , structural MRI , and intervention studies to explore these domains, with recent work addressing emotional processing and metabolic influences on mental health.

پروفایل رسمی دانشگاه

Yvonne M. Ulrich-Laiمشاهده پروفایل

استاد

University of CincinnatiUnited States

Dr. Yvonne M. Ulrich-Lai is a Professor in the Department of Pharmacology and Systems Physiology at the University of Cincinnati. Her research focuses on the neural and hormonal mechanisms linking diet, obesity, and stress, particularly the role of the HPA axis and reward systems in behavioral and physiological stress responses. PhD in Neuroscience, University of Minnesota (2002) Postdoctoral Fellowship, University of Cincinnati College of Medicine (2007) BSc in Biology, Harvey Mudd College (1994) Her work investigates: How comfort foods modulate stress through brain reward pathways Ketogenic diets' impact on HPA axis activity Sexual dimorphism in stress-induced metabolic dysfunctions Neuroanatomical circuits regulating stress-food interactions Recent publications highlight her focus on rodent models to study diet-induced obesity, HPA axis plasticity, and stress-related behavioral changes. Scientific awards include the 2012 Amgen/Endocrine Society Early Investigators Award . She holds multiple federal grants from NIDDK and NIMH, including R01 and R56 awards, and collaborates with interdisciplinary teams on metabolic phenotyping and stress resilience.

پروفایل رسمی دانشگاه

Edythe Londonمشاهده پروفایل

استاد

University of California, Los AngelesUnited States

Edythe London, Ph.D., is a Distinguished Professor-in-Residence at UCLA with joint appointments in the Departments of Psychiatry and Biobehavioral Sciences and Molecular & Medical Pharmacology. She holds membership in the Brain Research Institute, CTSI Molecular Pharmacology, and Neuroscience GPB Home Area. Her research utilizes neuroimaging to investigate neural circuitry underlying addiction and self-control behaviors. She earned her Ph.D. in Pharmacology from the University of Maryland and completed postdoctoral training at Johns Hopkins School of Medicine. Prior to joining UCLA in 2001, she directed the NIDA Brain Imaging Center and held faculty positions at the University of Maryland and Johns Hopkins. Dr. London's research focuses on neuroimaging of addiction mechanisms, with emphasis on: Neural substrates of methamphetamine and nicotine dependence mGlu5 receptor function in substance use disorders Sex differences in neuropharmacology Structural and functional brain alterations in addiction Neuromodulation therapies for craving reduction Her publications demonstrate consistent focus on addiction neurobiology, particularly through multi-modal neuroimaging (fMRI, PET, MRS) and large-scale consortia work with ENIGMA-Addiction. Significant honors include: Nathan B. Eddy Lifetime Achievement Award (2023) McLean Hospital Women in Science Lectureship (2020) H.W. Magoun Lectureship (2019) AAAS Scientific Freedom & Responsibility Award (2011) She leads translational research through NIH-funded projects on neuropharmacological interventions and maintains extensive collaborations through the ENIGMA-Addiction Working Group.

پروفایل رسمی دانشگاه

John A. Daniمشاهده پروفایل

استاد

University of PennsylvaniaUnited States

John A. Dani, PhD is the David J. Mahoney Professor of Neurological Sciences and Chair of the Department of Neuroscience at the University of Pennsylvania's Perelman School of Medicine. He also serves as Scientific Director of the University of Pennsylvania Health System and Director of the Mahoney Institute for Neurosciences (MINS). With a distinguished career spanning Yale University, Baylor College of Medicine, and UPENN, Dr. Dani has made groundbreaking contributions to understanding addiction mechanisms, particularly nicotine's effects on neural learning and memory systems. His research focuses on Neurotransmitter signaling in addiction Neuroplasticity in mental disorders Systems neuroscience approaches Neural mechanisms of memory Dr. Dani's recent publications highlight his work on Genetic variations in nicotine addiction Serotonin-dopamine interactions Stress-related neural adaptations Developmental exposure effects His laboratory employs advanced techniques including In vivo electrophysiology Neurophysiological modeling Behavioral task design Brain slice recordings

پروفایل رسمی دانشگاه

Cristina Anna Colomboمشاهده پروفایل

استاد

Vita-Salute San Raffaele UniversityItaly

Cristina Anna Colombo is a Full Professor of Psychiatry at Vita-Salute San Raffaele University’s School of Medicine. She holds leadership positions including Head of the Mood Disorders Unit at San Raffaele Hospital in Milan. Her career spans over three decades, with expertise in neurobiology, psychopharmacology, and chronotherapeutics. Colombo earned her medical degree from the University of Milan in 1985, completing residencies in Psychiatry and specializing in clinical neurosciences. Her research focuses on mood disorders, particularly bipolar disorder, schizophrenia, and the neurobiological mechanisms underlying depression. She pioneered studies on sleep deprivation therapy, light therapy, and genetic factors influencing treatment responses. Her work integrates neuroimaging (MRI, PET), pharmacogenetics, and chronobiology to understand mental health disorders. Colombo has authored over 125 peer-reviewed articles and book chapters, with notable contributions on serotonin transporter gene polymorphisms and lithium’s neuroprotective effects. She directs postgraduate courses in forensic psychopathology and security professions at her university. Her clinical and academic roles emphasize translational research, bridging neurobiological insights with clinical practice. Her awards and honors include board certifications in Psychiatry and Criminology (cum laude), and her leadership in international congresses highlights her global impact. Colombo’s work continues to advance treatment strategies for mood disorders, emphasizing personalized medicine and non-pharmacological interventions.

پروفایل رسمی دانشگاه

Katherine Beckمشاهده پروفایل

مدرس

King’s College LondonUnited Kingdom

Dr. Katherine Beck is an NIHR Clinical Lecturer at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience and an Honorary Consultant Psychiatrist at South London and Maudsley NHS Foundation Trust. She completed her PhD on neuroimaging in psychosis funded by Rosetrees Trust and Royal College of Psychiatrists. Her research focuses on schizophrenia neurobiology, glutamate systems, and treatment-resistant psychosis. Education: PhD (King’s College London), Medical Degree. Research interests include neuroimaging techniques (PET/MRI), glutamate dysregulation in schizophrenia, and novel drug development targeting neural circuits. She leads studies on NMDA receptors, clozapine efficacy, and psychedelic drugs’ psychiatric implications. Key awards include Royal Society of Medicine and Schizophrenia International Research Society recognitions. She developed a specialized service for treatment-resistant schizophrenia patients and collaborates internationally across 15 countries.

پروفایل رسمی دانشگاه

Aryn Gittisمشاهده پروفایل

دانشیار

Carnegie Mellon UniversityQatar

Dr. Aryn Gittis is an Associate Professor in the Department of Biological Sciences and Neuroscience Institute at Carnegie Mellon University. Her lab investigates the neural basis of motor control, focusing on basal ganglia circuits in health and disease using optogenetics, electrophysiology, and behavioral assays. Research spans computational neuroscience, motor disorders, and neural circuit dynamics. Her work explores how basal ganglia organization shapes movement, with emphasis on Parkinson's pathophysiology and therapeutic neuromodulation. Research integrates molecular, physiological, and systems-level approaches to decode circuit mechanisms. Recent publications center on deep brain stimulation, Parkinson's disease models, basal ganglia circuitry, and neural oscillations. Trends include therapeutic applications of circuit-specific neuromodulation and computational analysis of motor pathways. Students Advised: Current advisees include Isabella Salas-Allende (MD/PhD), with recent graduates Dr. Mary Cundiff, Dr. Katrina Nguyen, and Dr. Brian Isett contributing to key publications. Laboratory: The Gittis Lab employs optogenetics, electrophysiology, and behavioral methods to study basal ganglia function and develop interventions for movement disorders.

پروفایل رسمی دانشگاه

Ed Wagnerمشاهده پروفایل

استاد

Western University of Health SciencesUnited States

Ed Wagner, PhD Ed Wagner is a Professor of Physiology at the College of Osteopathic Medicine of the Pacific (COMP) at Western University of Health Sciences. He joined the institution in 2001 and has held roles including Director of the MSBS Program since 2018. His academic career spans over three decades, with postdoctoral training at Oregon Health Sciences University and faculty appointments in Pharmacology, Neuroscience, and Physiology. Education Dual Ph.D. in Pharmacology & Toxicology/Neuroscience, Michigan State University (1994) B.S. in Psychobiology, UCLA (1986) Orange Coast College (1983) Research Focus Wagner’s work centers on sex differences in cannabinoid regulation of energy homeostasis and gonadal steroid modulation of hypothalamic circuits. Key areas include: Cannabinoid effects on feeding behavior Sex-specific responses to CB1 receptor agonists/antagonists Estrogen’s role in attenuating cannabinoid-induced effects Neuroendocrine control of energy balance via POMC and SF-1 neurons His lab employs optogenetic, chemogenetic, and molecular approaches, with NIH funding since 2017. Awards & Recognition Provost’s Distinguished Scholar Award (2018) WesternU College of Osteopathic Medicine Distinguished Faculty Award (2015) Invited speaker at conferences including the International Congress on Steroids and the Nervous System (multiple years) Grants & Funding NIH R15 Grant (2017–2020): Investigating sex differences in cannabinoid regulation of energy homeostasis. Prior grants include NIDA K01 and NICHD R01 support. Labs & Collaborations Leads a research group focusing on neuroendocrine mechanisms, collaborating with institutions like UCLA and University of North Texas. Active in mentoring students in the MSBS Program.

پروفایل رسمی دانشگاه

Kenneth D. Carrمشاهده پروفایل

استاد

New York UniversityUnited States

Kenneth D. Carr serves as Professor in both the Department of Psychiatry and Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine, New York University. His academic office is located at 435 East 30th Street, Tenth Floor, New York, NY 10016, with contact phone 212-263-5749. Education: PhD, New York University Dr. Carr's research spans molecular, cellular, and translational neuroscience , pharmacology , and systems neuroscience , with core focus on the neurobiology of ingestive behavior and drug addiction . His work investigates dopamine signaling, reward mechanisms, AMPA receptors , and insulin in neural pathways, particularly examining diet-insulin interactions in addiction models. Recent publications (2019-2024) demonstrate consistent exploration of high fat-high sugar diets on neural reward systems, sex-specific responses to food restriction in cocaine preference, and receptor mechanisms (RAGE, AMPA) in nucleus accumbens. Rodent behavioral models dominate his methodology, with emphasis on insulin-dopamine crosstalk and diet-induced neuroadaptations. Scientific Awards: No scientific awards listed in the provided text Advising & Grants: The profile does not specify current students or grant funding. His extensive publication record (151 total) suggests active research leadership and potential NIH or institutional grant support, but no advising relationships or grant details are documented here. Collaborative publications indicate work with neuroscience researchers like Sydney P. Weiner and Robert C. Froemke. Labs & Teams: Research is conducted within NYU's Department of Psychiatry and Department of Biochemistry and Molecular Pharmacology. The text references no named laboratory or dedicated research team, but his work involves multi-investigator collaborations as evidenced by co-authored publications spanning behavioral neuroscience and molecular pharmacology.

پروفایل رسمی دانشگاه